Get the content you want anytime you want.

Six Presidential Advisory Council on HIV/AIDS Members Resign: Public Health Watch Report

“This means no one is tasked with regularly bringing salient issues regarding this ongoing public health crisis to the attention of the President and his closest advisers,” Schoettes writes.
This very public announcement is only the latest in a series of “resignations-in-protest” for the Trump administration, which saw the abrupt departure of several State Department officials within days of taking office. In addition, two key scientific advisers to the Environmental Protection Agency stepped down in May in response to the President’s stance on climate change.
But while it’s safe to say that the vast majority of Contagion® readers are aware of PACHA and its work, it’s likely that all-too-few Americans had heard of the council prior to the Newsweek commentary and its fallout. Many Americans might also be surprised to learn that, despite the significant advancements made in HIV/AIDS treatment and prevention in recent years, many of those affected with the disease lack access to proper care—even here in the United States.
According to the UNAIDS “Prevention Gap” report, which was published in 2016, only some 30,000 of the 1.2 million Americans eligible for HIV PrEP (preexposure prophylaxis) therapy were prescribed the approach in 2015; in addition, some 13% of those who are HIV-positive are unaware of their status, and only 56.5% of those with the disease receive regular care. Some media analyses are reporting that these numbers are expected to worsen should the American Health Care Act and related changes to Medicare and Medicaid take effect.
“Because we do not believe the Trump Administration is listening to—or cares—about the communities we serve as members of PACHA, we have decided it is time to step down,” Schoettes writes. “We will be more effective from the outside, advocating for change and protesting policies that will hurt the health of the communities we serve...”
For now, those living with HIV/AIDS, and those who treat them, will have to hope Schoettes and his colleagues are right about that.
Brian P. Dunleavy is a medical writer and editor based in New York. His work has appeared in numerous healthcare-related publications. He is the former editor of Infectious Disease Special Edition. 
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.

Big advances in treatment can